https://www.pharmanow.live/latest-news/artelo-biosciences-art2713-glp1-combination-weight-loss-nonclinical-data 2026-11-12T21:55:37+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Artelo Biosciences Achieves 40% Weight Loss in GLP-1 Combination Nonclinical Study Artelo https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/cccfbc34-751f-47ac-b535-61c39708cbf9.png https://www.pharmanow.live/latest-news/grace-therapeutics-dual-source-cmo-strategy-gtx-104-nda-resubmission 2026-11-12T21:57:41+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Grace Therapeutics Advances Dual-Source CMO Strategy Grace https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/00c59e34-7bd6-453e-ab1e-1a3a8626b50e.png https://www.pharmanow.live/latest-news/monopar-therapeutics-rolling-nda-submission-alxn1840-wilson-disease 2026-11-12T21:51:49+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Monopar Therapeutics Advances Rolling NDA Submission in Wilson Disease https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png